A Study in Healthy Men to Test How Different Doses of BI 3032950 Are Tolerated
NCT05518708
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
94
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
BI 3032950
DRUG:
Placebo
Sponsor
Boehringer Ingelheim